PT-006 - HYPOALBUMINEMIA EARLY IN TREATMENT HINDERS BENEFIT FROM IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED CANCERS.

Y. Guo¹, S. Kulp¹, T. Mace², C. Coss¹, M. Phelps¹, D. Owen²; ¹The Ohio State University, Columbus, OH, USA, ²James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.

Presenting Author(s)

Yizhen Guo, PharmD

Postdoctoral Scholar
The Ohio State University Comprehensive Cancer Center
UPPER ARLINGTON, Ohio, United States